title: [Targeting apoptosis signaling pathways in cancer therapy].
authors.affiliation: liang_cheng@yahoo.com
authors.forename: Liang
authors.initials: L
authors.lastname: Cheng
authors.forename: Xi
authors.initials: X
authors.lastname: Wang
authors.forename: Jie
authors.initials: J
authors.lastname: Zhang
authors.forename: Shao-bo
authors.initials: SB
authors.lastname: Zhang
authors.forename: Su-qin
authors.initials: SQ
authors.lastname: Zheng
authors.forename: Jie
authors.initials: J
authors.lastname: Zheng
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D020169:Caspases / Q000378:metabolism* / Q000502:physiology; D004789:Enzyme Activation; D053222:Fas Ligand Protein / Q000378:metabolism; D006801:Humans; D016328:NF-kappa B / Q000378:metabolism; D009369:Neoplasms / Q000378:metabolism / Q000628:therapy*; D009389:Neovascularization, Pathologic; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D000970:Antineoplastic Agents; D053222:Fas Ligand Protein; D016328:NF-kappa B; D019253:Proto-Oncogene Proteins c-bcl-2; D020169:Caspases